<DOC>
	<DOCNO>NCT02979509</DOCNO>
	<brief_summary>All patient receive standard medical care experimental intervention perform . Endoscopic ultrasound-guided fine-needle aspiration ( EUS-FNA ) well-established procedure commonly use investigation lesion within adjacent gastrointestinal ( GI ) lumen ( i.e . pancreas , liver , mediastinal mass , leave adrenal gland , lymph node , subepithelial lesion ) . EUS-guided tissue sample commonly perform different size type aspiration core biopsy needle .</brief_summary>
	<brief_title>Evaluation Diagnostic Yield EUS-Guided Tissue Sampling</brief_title>
	<detailed_description>Endoscopic ultrasound-guided fine-needle aspiration ( EUS-FNA ) well-established procedure commonly use investigation lesion within adjacent gastrointestinal ( GI ) lumen ( i.e . pancreas , liver , mediastinal mass , leave adrenal gland , lymph node , subepithelial lesion ) . EUS-guided tissue sample commonly perform different size type aspiration core biopsy needle . More recently , novel through-the-needle microforceps introduce . The MorayTM microforceps fit 19-gauge FNA needle allow target tissue sample EUS visualization . Aim - To prospectively evaluate safety diagnostic yield through-the-needle microforceps pancreatic non-pancreatic solid , cystic mixed solid/cystic lesion .</detailed_description>
	<criteria>1 . Age &gt; 18 year old 2 . Patients refer EUSguided tissue sample lesion ( i.e . pancreas , liver , mediastinal mass , leave adrenal gland , lymph node , subepithelial lesion ) . 3 . Target lesion â‰¥ 15 mm size ( long axis ) . 1 . Any contraindication perform endoscopy 2 . Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>